Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia

The clinically ideal time point and optimal approach for the assessment of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) are still inconclusive. We investigated the clinical value of multiparameter flow cytometry-based MRD (MFC MRD) after induction (n = 492) and two...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Liu, Fu-Jia, Cheng, Wen-Yan, Lin, Xiao-Jing, Wang, Shi-Yang, Jiang, Tian-Yi, Ma, Ting-Ting, Zhu, Yong-Mei, Shen, Yang
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2021
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8173083/
https://ncbi.nlm.nih.gov/pubmed/34094982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.677833
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items